GJA1 and hepatocellular carcinoma: Cx43 mRNA was analyzed in 38 specimens from patients with HBV-HCC and a low AFP level, whose early recurrence rate was 26.7%; of these specimens, the Cx43 mRNA+ rate was 57.9%.